|
|
|
The Permission for Clinical Trial for Recombinant Anti-VEGF Humanized Monoclonal Antibody Injection was issued 2017-02-01 10:35 |
|
|
|
“Recombinant Anti-VEGF Humanized Monoclonal Antibody Injection” was approved to conduct clinical trial by CFDA on 23rd, January in 2017. |
|
|
|
|
|
沪ICP备10027510号-1